Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Current Taxes (2016 - 2025)

Historic Current Taxes for Trinity Biotech (TRIB) over the last 17 years, with Q2 2025 value amounting to $472000.0.

  • Trinity Biotech's Current Taxes rose 6678.45% to $472000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $472000.0, marking a year-over-year increase of 6678.45%. This contributed to the annual value of $364000.0 for FY2024, which is 3046.59% up from last year.
  • Per Trinity Biotech's latest filing, its Current Taxes stood at $472000.0 for Q2 2025, which was up 6678.45% from $364000.0 recorded in Q4 2024.
  • Trinity Biotech's Current Taxes' 5-year high stood at $1.0 million during Q3 2021, with a 5-year trough of $21000.0 in Q2 2022.
  • Its 5-year average for Current Taxes is $290000.0, with a median of $283000.0 in 2024.
  • In the last 5 years, Trinity Biotech's Current Taxes crashed by 9793.71% in 2022 and then soared by 126666.67% in 2023.
  • Trinity Biotech's Current Taxes (Quarter) stood at $22000.0 in 2021, then rose by 27.27% to $28000.0 in 2022, then surged by 896.43% to $279000.0 in 2023, then soared by 30.47% to $364000.0 in 2024, then increased by 29.67% to $472000.0 in 2025.
  • Its Current Taxes was $472000.0 in Q2 2025, compared to $364000.0 in Q4 2024 and $333000.0 in Q3 2024.